Please login to the form below

Not currently logged in
Email:
Password:

outcomes

This page shows the latest outcomes news and features for those working in and with pharma, biotech and healthcare.

Janssen’s EGFR-targeting treatment regimen shows early benefit in lung cancer

Janssen’s EGFR-targeting treatment regimen shows early benefit in lung cancer

EGFR-mutated NSCLC often develops resistance to EGFR-targeting drugs like Tagrisso over time, highlighting the need for new therapies designed to improve outcomes for patients whose options are otherwise limited.

Latest news

More from news
Approximately 14 fully matching, plus 1,789 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 10 fully matching, plus 482 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 64 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 9 fully matching, plus 526 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Hanover Communications

Healthcare is evolving rapidly. To stand out from the crowd requires a potent combination of rich insight, innovative ideas and...

Latest intelligence

Kulveer Singh
Surviving cancer: a new era for patients
Now more than ever, a shift in perspective is needed...
Crisis? No problem!
Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....

Infographics